NCT03404856View on ClinicalTrials.gov

Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 31, 2017

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Glycogen Storage Disease, Type 14
Interventions
DRUG

ORL-1G - D-galactose

Oral ORL-1G - D-galactose

Trial Locations (1)

06100

RECRUITING

Orpha Labs, Ankara

Sponsors

Lead Sponsor

Orpha Labs
All Listed Sponsors
lead

Orpha Labs

INDUSTRY

NCT03404856 - Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14 | Biotech Hunter | Biotech Hunter